Chemical and Pharmacological Properties of Decoquinate: A Review of Its Pharmaceutical Potential and Future Perspectives.

antimicrobial decoquinate medicinal chemistry nanomedicines physicochemical properties

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
30 Jun 2022
Historique:
received: 01 05 2022
revised: 07 06 2022
accepted: 09 06 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 28 7 2022
Statut: epublish

Résumé

Decoquinate (DQ) is an antimicrobial agent commonly used as a feed additive for birds for human consumption. Its use as an additive is well established, but DQ has the potential for therapy as an antimicrobial drug for veterinary treatment and its optimized derivatives and/or formulations, mainly nanoformulations, have antimicrobial activity against pathogens that infect humans. However, DQ has a high partition coefficient and low solubility in aqueous fluids, and these biopharmaceutical properties have limited its use in humans. In this review, we highlight the antimicrobial activity and pharmacokinetic properties of DQ and highlight the solutions currently under investigation to overcome these drawbacks. A literature search was conducted focusing on the use of decoquinate against various infectious diseases in humans and animals. The search was conducted in several databases, including scientific and patent databases. Pharmaceutical nanotechnology and medicinal chemistry are the tools of choice to achieve human applications, and most of these applications have been able to improve the biopharmaceutical properties and pharmacokinetic profile of DQ. Based on the results presented here, DQ prototypes could be tested in clinical trials for human application in the coming years.

Identifiants

pubmed: 35890280
pii: pharmaceutics14071383
doi: 10.3390/pharmaceutics14071383
pmc: PMC9315532
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Coordenação de Aperfeicoamento de Pessoal de Nível Superior
ID : Finance Code 001

Références

Vet Parasitol. 2013 Sep 1;196(1-2):21-3
pubmed: 23523012
Nat Med. 2021 Aug;27(8):1333-1337
pubmed: 34226736
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2015;32(7):1124-8
pubmed: 25952987
Drug Des Devel Ther. 2017 Feb 13;11:393-406
pubmed: 28243062
Nat Commun. 2016 Jun 15;7:11901
pubmed: 27301419
Vet Med (Auckl). 2014 Apr 28;5:23-34
pubmed: 32670843
Curr Opin Chem Biol. 2010 Aug;14(4):440-6
pubmed: 20570550
Can Vet J. 2013 Jul;54(7):693-7
pubmed: 24155466
Vet Parasitol. 2020 Jul;283:109186
pubmed: 32683214
Vet Parasitol. 2018 Sep 15;261:77-85
pubmed: 30253854
Int J Parasitol. 1997 Jan;27(1):101-11
pubmed: 9076535
J Parasitol. 1993 Aug;79(4):559-64
pubmed: 8331476
Int J Pharm. 2020 Sep 25;587:119710
pubmed: 32739383
Bioorg Med Chem Lett. 2016 Jul 1;26(13):3006-3009
pubmed: 27210430
Clin Infect Dis. 2005 Jul 15;41 Suppl 2:S113-9
pubmed: 15942877
Nat Chem. 2022 Jan;14(1):112
pubmed: 34997226
Front Pharmacol. 2019 Feb 18;10:120
pubmed: 30833898
Pharm Res. 2018 Aug 7;35(10):186
pubmed: 30088097
Nature. 2019 Mar;567(7747):239-243
pubmed: 30814727
Cell Chem Biol. 2020 Feb 20;27(2):158-171.e3
pubmed: 31813848
Mem Inst Oswaldo Cruz. 2012 Nov;107(7):831-45
pubmed: 23147137
EFSA J. 2019 Jan 14;17(1):e05541
pubmed: 32626086
J Vet Pharmacol Ther. 2012 Oct;35(5):417-27
pubmed: 22724547
J Control Release. 1999 Jun 28;60(1):67-76
pubmed: 10370172
Molecules. 2020 Dec 01;25(23):
pubmed: 33271787
Malar J. 2014 Aug 30;13:339
pubmed: 25176157
N Engl J Med. 2014 Oct 23;371(17):1642-3
pubmed: 25337754
J Med Chem. 2012 Feb 9;55(3):995-1012
pubmed: 22122518
Front Microbiol. 2018 Oct 29;9:2587
pubmed: 30420849
Pharm Res. 1995 Nov;12(11):1561-72
pubmed: 8592652
Exp Parasitol. 2019 Jun;201:34-41
pubmed: 31034815
J Infect Dis. 2012 Apr 15;205(8):1278-86
pubmed: 22396598
Vet Rec. 1996 May 4;138(18):434-6
pubmed: 8735260
Drug Des Devel Ther. 2020 Sep 22;14:3875-3889
pubmed: 33061294
Vet Rec. 2005 Aug 27;157(9):261-2
pubmed: 16127138
Curr Top Med Chem. 2018;18(15):1304-1323
pubmed: 30277158
FEMS Yeast Res. 2008 Mar;8(2):183-92
pubmed: 18093133
Pharm Res. 1995 Mar;12(3):413-20
pubmed: 7617530
Antibiotics (Basel). 2021 Jun 10;10(6):
pubmed: 34200519
Biochem Pharmacol. 1984 Jan 15;33(2):229-40
pubmed: 6704148
Drug Resist Updat. 2001 Apr;4(2):79-84
pubmed: 11512524
Avian Pathol. 1998;27(1):67-73
pubmed: 18483966
Int J Antimicrob Agents. 2018 Mar;51(3):304-310
pubmed: 28935212
Curr Opin Infect Dis. 2011 Dec;24(6):578-85
pubmed: 21986614
Malar J. 2022 Jan 24;21(1):24
pubmed: 35073922
Trends Parasitol. 2017 Mar;33(3):185-193
pubmed: 27789127
Mol Biochem Parasitol. 2019 Sep;232:111204
pubmed: 31381948
Eur J Med Chem. 2013 Aug;66:555-62
pubmed: 23528390
West J Med. 1999 Jun;170(6):359-61
pubmed: 10443165
Vet Rec. 2006 Nov 11;159(20):672-6
pubmed: 17099176
Malar Res Treat. 2017;2017:7508291
pubmed: 28491482
Vet Parasitol. 2011 Sep 8;181(1):3-11
pubmed: 21620568
Vet Parasitol. 2006 Jan 15;135(1):1-14
pubmed: 16289564
Eur J Pharm Sci. 2014 Jun 16;57:152-63
pubmed: 24486482
AAPS PharmSciTech. 2019 Jan 2;20(1):33
pubmed: 30604176
Front Pharmacol. 2020 May 19;11:724
pubmed: 32508649
Vet Parasitol. 1997 Apr;69(1-2):31-7
pubmed: 9187027
EFSA J. 2021 Mar 08;19(3):e06453
pubmed: 33732399
Malar Res Treat. 2013;2013:769234
pubmed: 23766925
Acta Trop. 2017 Jun;170:16-42
pubmed: 28232069
Biomed Res Int. 2021 Aug 30;2021:5539544
pubmed: 34497848
Antimicrob Agents Chemother. 1993 Nov;37(11):2358-63
pubmed: 8285619
Nanomedicine. 2014 Jan;10(1):57-65
pubmed: 23891618
J Am Vet Med Assoc. 2001 Jan 1;218(1):77-82
pubmed: 11149719
Poult Sci. 2008 Oct;87(10):2052-63
pubmed: 18809868
Int J Pharm. 2017 Aug 30;529(1-2):134-160
pubmed: 28642203
Mitochondrion. 2014 Jul;17:116-25
pubmed: 25034306
Bioorg Med Chem Lett. 2013 Sep 1;23(17):4741-50
pubmed: 23910985
J R Soc Med. 2017 Jan;110(1):31-40
pubmed: 28106483
Nat Rev Microbiol. 2014 Mar;12(3):159-67
pubmed: 24487820
J Med Chem. 2012 Dec 13;55(23):10328-44
pubmed: 23075290
Parasitol Res. 2019 Jul;118(7):2009-2026
pubmed: 31152233
Vet Parasitol. 1997 Jan;68(1-2):35-40
pubmed: 9066049
Nanomaterials (Basel). 2021 Apr 22;11(5):
pubmed: 33922004
J Sci Food Agric. 1969 Feb;20(2):70-3
pubmed: 5777009
ACS Chem Biol. 2011 Nov 18;6(11):1214-22
pubmed: 21866942
Biochim Biophys Acta. 1975 Aug 11;396(2):210-9
pubmed: 1171697

Auteurs

Tainá Santos Souza (TS)

Graduation Program in Pharmacy, College of Pharmacy, Federal University of Bahia, Salvador 40170-115, BA, Brazil.

Diogo Rodrigo Magalhães Moreira (DRM)

Fundação Oswaldo Cruz (Fiocruz), Instituto Gonçalo Moniz, Salvador 40296-710, BA, Brazil.

Henrique Rodrigues Marcelino (HR)

Graduation Program in Pharmacy, College of Pharmacy, Federal University of Bahia, Salvador 40170-115, BA, Brazil.
Department of Medicines, College of Pharmacy, Federal University of Bahia, Salvador 40170-115, BA, Brazil.

Classifications MeSH